KLK3 and benign prostatic hyperplasia: They found that the diagnostic concordance of combined assessment of magnetic resonance imaging (MRI), PSA, soluble E-calmodulin, and EPCA-2 for identifying PCa and BPH was 93%, significantly higher than that of the separate method.